News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
109–144
Matches
370
Sources here
15
Companies here
8
Search results Stored financial headlines

Active search

370 matching headlines

Ticker or company: ROBOMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Arbe Robotics Ltd (ARBE) (Q2 2026) Earnings Call Highlights: Revenue Growth and Defense ...

Arbe Robotics Ltd reported revenue of $0.7 million in Q2 2026, marking its third consecutive quarter of growth, and reduced its operating loss to $9.8 million. The company is expanding into the defense and robotaxi markets, securing a framework agreement with a global defense …

ARBE main company
Sharemaestro market context Price below Trend Line 52 weeks -38.7% ARBE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Serve Robotics is Crashing: Buy the Dip?

This article questions whether investors should buy Serve Robotics stock after a recent crash. It highlights that The Motley Fool's Stock Advisor team did not include Serve Robotics in their top 10 stock recommendations, instead suggesting other companies with significant potential returns. The piece …

SERV main company
Sharemaestro market context Price below Trend Line 52 weeks -48.6% SERV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings call transcript: Serve Robotics Q2 2026 revenue rises, but stock falls on guidance cut

Serve Robotics reported Q2 2026 revenue of $3.2 million, a 400% increase year-over-year, but shares fell 11% in after-hours trading due to a significant cut in full-year revenue guidance from $26 million to $9 million-$10 million. The guidance cut is primarily attributed to a …

SERV main company
Sharemaestro market context Price below Trend Line 52 weeks -48.6% SERV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Serve Robotics Inc. (SERV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Serve Robotics Inc. (SERV) reported Q2 2026 revenue of $3.24 million, a 405.9% increase year-over-year, but missed the Zacks Consensus Estimate by 8.45%. The company posted an EPS of -$0.80, worse than the -$0.36 from the prior year and missing the consensus estimate of …

SERV main company
Sharemaestro market context Price below Trend Line 52 weeks -48.6% SERV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Serve Robotics Inc. (SERV) Reports Q2 Loss, Lags Revenue Estimates

Serve Robotics Inc. (SERV) reported a Q2 loss of $0.8 per share, missing the Zacks Consensus Estimate of a $0.69 loss, and revenues of $3.24 million, falling short of estimates by 8.45%. The company's shares have declined 45.5% year-to-date, contrasting with the S&P 500's …

SERV main company
Sharemaestro market context Price below Trend Line 52 weeks -48.6% SERV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Serve Robotics (NYSE: SERV) surges 404% in Q2 revenue, trims 2026 guidance

Serve Robotics reported significant revenue growth in Q2 2026, with a 404% year-over-year increase to $3.2 million, driven by diversified revenue streams including healthcare and a DoorDash partnership. Despite this growth, the company experienced substantial GAAP net losses and negative adjusted EBITDA. Serve Robotics …

SERV main company
Sharemaestro market context Price below Trend Line 52 weeks -48.6% SERV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arbe Robotics Ltd reports results for the quarter ended June 30 - Earnings Summary

Arbe Robotics Ltd has reported its earnings for the quarter that ended on June 30. The summary of these results is available through Reuters on TradingView, with full access provided through a subscription.

ARBE main company
Sharemaestro market context Price below Trend Line 52 weeks -38.7% ARBE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arbe Robotics earnings beat by $0.02, revenue topped estimates

Arbe Robotics (NASDAQ: ARBE) reported second-quarter earnings per share of $-0.060, exceeding analyst estimates by $0.02. The company's revenue for the quarter was $703K, surpassing the consensus estimate of $631.83K. Despite the earnings beat, Arbe Robotics' stock has seen a decline of -11.860% in …

ARBE main company
Sharemaestro market context Price below Trend Line 52 weeks -38.7% ARBE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arbe Robotics (NASDAQ: ARBE) posts Q2 2026 results, names new CFO

Arbe Robotics reported Q2 2026 revenues of $0.7 million, an increase from $0.3 million in Q2 2025, with a narrowed net loss of $9.1 million compared to $10.2 million a year prior. The company maintained a strong cash position of $41.9 million and reaffirmed …

ARBE main company ARBE main company
Sharemaestro market context Price below Trend Line 52 weeks -46.9% ARBE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arbe Appoints Assaf Pereg, CPA, as Chief Financial Officer – Company Announcement

Arbe Robotics Ltd. has announced the appointment of Assaf Pereg, CPA, as its new Chief Financial Officer, effective August 30, 2026. Mr. Pereg brings extensive financial leadership experience from various technology companies and will succeed Karine Pinto-Flomenboim. This appointment comes as Arbe transitions from …

ARBE main company
Sharemaestro market context Price below Trend Line 52 weeks -38.7% ARBE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PROCEPT BioRobotics (PRCT) Stock Rises As Revenue Holds Firm And Losses Deepen

PROCEPT BioRobotics (PRCT) stock rose by 5.8% after its Q2 earnings report, despite widening losses. The company reported Q2 sales of US$94.5m and maintained its full-year revenue guidance, indicating sustained growth. However, net losses deepened to US$26.9m, highlighting the company's challenge in balancing revenue …

PRCT main company
Sharemaestro market context Price below Trend Line 52 weeks -47.5% · Next-week setup negative 44.9% PRCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PROCEPT BioRobotics Corp 1Q 2026: Revenue $94.5M, EPS ($0.47) — 10-Q Summary

PROCEPT BioRobotics Corp (PRCT) reported its first-quarter 2026 results, showing revenue growth to $94.5 million, an increase of 19.3% year-over-year. Despite the revenue rise, the company recorded a net loss of ($26.86M) and a diluted loss per share of ($0.47), both widening compared to …

PRCT main company
Sharemaestro market context Price below Trend Line 52 weeks -47.5% · Next-week setup negative 44.9% PRCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings To Watch: Arbe Robotics Ltd (ARBE) Q2 2026 -- GF Value Sees 50% Upside

Arbe Robotics Ltd (ARBE) is preparing to release its Q2 2026 earnings, with consensus estimates predicting $0.5 million in revenue and a loss of $0.08 per share. For the full year 2026, revenue is projected at $4.5 million and a loss of $0.28 per …

ARBE main company
Sharemaestro market context Price below Trend Line 52 weeks -38.7% ARBE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kaplan Fox Notifies PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors of a Securities Class Action Deadline on September 22, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased common stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT artificially inflated reported U.S. handpiece unit …

PRCT main company
Sharemaestro market context Price below Trend Line 52 weeks -47.5% · Next-week setup negative 44.9% PRCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

[10-Q] PROCEPT BioRobotics Corp Quarterly Earnings Report

PROCEPT BioRobotics Corp. filed its Form 10-Q quarterly report for the period ending June 30, 2026, disclosing a net loss of $58.5 million on revenues of $177.6 million for the first six months of 2026. The company reported $227.9 million in cash and cash …

PRCT main company
Sharemaestro market context Price below Trend Line 52 weeks -47.5% · Next-week setup negative 44.9% PRCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LFWD Q2'26 Earnings: revenue estimate is 6.53M USD

Lifeward Ltd. (LFWD) is expected to announce its Q2'26 earnings on August 12, with a revenue estimate of $6.53 million and an anticipated EPS of -$1.39. The article provides a detailed table comparing past reported and estimated revenues and EPS, including surprise percentages, for …

LFWD main company
Sharemaestro market context Trend signal active 52 weeks +0.9% · Next-week setup negative 36.3% LFWD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Lifeward Launches ReWalk 7 Pilot Program with Ottobock Care to Expand U.S. Patient Access

Lifeward Ltd. has partnered with Ottobock Care to launch a six-month pilot program aimed at increasing U.S. patient access to the ReWalk® 7 Personal Exoskeleton. The initiative will leverage Ottobock Care's extensive clinical expertise and patient care infrastructure across over 50 clinics to raise …

LFWD main company
Sharemaestro market context Trend signal active 52 weeks +0.9% · Next-week setup negative 36.3% LFWD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PROCEPT BioRobotics reports Q2 2026 revenue $94.5M, net loss $26.9M, reiterates FY26 revenue guide

PROCEPT BioRobotics reported Q2 2026 revenue of $94.5 million and a net loss of $26.9 million, while reiterating its full-year 2026 revenue guidance of $390 million to $410 million. The company achieved a 19% year-over-year revenue increase, with U.S. procedures growing by approximately 21% …

PRCT main company
Sharemaestro market context Price below Trend Line 52 weeks -47.5% · Next-week setup negative 44.9% PRCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PROCEPT BioRobotics (NASDAQ:PRCT) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS

PROCEPT BioRobotics Corp. filed its Form 10-Q quarterly report for the period ending June 30, 2026, disclosing a net loss of $58.5 million on revenues of $177.6 million for the first six months of 2026. The company reported $227.9 million in cash and cash …

PRCT main company
Sharemaestro market context Price below Trend Line 52 weeks -47.5% · Next-week setup negative 44.9% PRCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Beats Revenue Estimates

PROCEPT BioRobotics Corporation (PRCT) reported a Q2 loss of $0.47 per share, slightly wider than the Zacks Consensus Estimate of a $0.46 loss, marking an earnings surprise of -2.17%. Despite the loss, the company surpassed revenue expectations, posting $94.5 million against an estimated $92.5 …

PRCT main company
Sharemaestro market context Price below Trend Line 52 weeks -47.5% · Next-week setup negative 44.9% PRCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Are Serve Robotics' (SERV) Growing Robot Fleet And Revenue Guidance Clarify Its Long-Term Profit Path?

Serve Robotics is seeing increased investor interest ahead of its Q2 2026 earnings, driven by its expanding fleet of approximately 2,000 autonomous delivery robots and reaffirmed full-year revenue guidance of about US$26.0 million. While this highlights short-term catalysts, the company still faces the significant …

SERV main company
Sharemaestro market context Price below Trend Line 52 weeks -48.6% SERV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Microbot Medical (MBOT) Expected to Announce Quarterly Earnings on Tuesday

Microbot Medical (MBOT) is anticipated to report its Q2 2026 earnings before the market opens on Tuesday, August 11th. Analysts project a loss of $0.08 per share on revenue of $0.333 million, with an investor call scheduled for August 13th. The company's previous quarter …

MBOT main company
Sharemaestro market context Price below Trend Line 52 weeks -59.7% MBOT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Procept Biorobotics earnings in spotlight as growth questions loom

Procept Biorobotics (NASDAQ:PRCT) is set to report second-quarter earnings, with investors focused on procedure growth amidst legal scrutiny and competitive pressures. Analysts anticipate a loss of 46 cents per share on revenue of $92.6 million, representing 17% year-over-year growth. The company faces class-action lawsuits …

PRCT main company
Sharemaestro market context Price below Trend Line 52 weeks -47.5% · Next-week setup negative 44.9% PRCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PROCEPT delivers 65 robotic systems as U.S. procedures pass 13,100

PROCEPT BioRobotics reported strong Q2 2026 financial results, with revenue up 19% year-over-year to $94.5 million, driven by increased U.S. handpiece, system sales, and international revenue. The company delivered 65 U.S. HYDROS robotic systems and U.S. procedures exceeded 13,100, marking a 21% increase. While …

PRCT main company
Sharemaestro market context Price below Trend Line 52 weeks -47.5% · Next-week setup negative 44.9% PRCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context